Patents by Inventor Phillip Yee

Phillip Yee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240099703
    Abstract: This disclosure describes a system, method, and non-transitory computer readable media for an ultrasound probe configured to capture ultrasound images of an examination region. The system includes a first set of one or more sensors coupled to the ultrasound probe and configured to estimate a first positional information associated with the ultrasound probe. The system includes a second set of one or more sensors coupled to the ultrasound probe and configured to capture electromagnetic force (EMF) measurements in the examination region to estimate a second positional information associated with the ultrasound probe. The second positional information is used to calibrate the first set of one or more sensors. The system includes a controller configured to use at least one of (i) the first positional information, or (ii) the second positional information to generate a reconstruction of the examination region based on ultrasound images captured by the ultrasound probe.
    Type: Application
    Filed: September 26, 2023
    Publication date: March 28, 2024
    Inventors: Alexander Martin Zoellner, Daniel Edward Rosenfeld, Ashley Quinn Swartz, John Paul Issa, Joseph Hollis Sargent, Ningrui Li, Phillip Yee, Ulrich Niemann, Qianyu Zhang
  • Publication number: 20240070427
    Abstract: Aspects of the disclosure provide systems including linear material and tracking tags. A first tracking tag may be at least initially arranged on the liner material. The first tracking tag may also include beacon transmission circuitry including one or more batteries, a top layer, a bottom layer including an adhesive, and an activation mechanism. The activation mechanism may be configured to activate the first tracking tag and cause the beacon transmission circuitry to transmit beacon signals in order to enable tracking of the object.
    Type: Application
    Filed: August 17, 2023
    Publication date: February 29, 2024
    Inventors: Shane Washburn, Jonathan Wilfong, Kin Seto, Haden Cory, Phillip Yee, Ricky Yik Hei Ngan, Dean Kawaguchi, Russell Shikami
  • Publication number: 20240070428
    Abstract: Aspects of the disclosure provide tracking tags. As an example, a tracking tag may include beacon transmission circuitry including one or more batteries, a frame configured to hold the one or more batteries in place, an adhesive arranged to secure the tracking tag to an object, and an activation mechanism configured to activate the tracking tag and cause the beacon transmission circuitry to transmit beacon signals in order to enable tracking of the object.
    Type: Application
    Filed: August 1, 2023
    Publication date: February 29, 2024
    Inventors: Ricky Yik Hei Ngan, Phillip Yee, Connor Burgess, Dean Kawaguchi, Kin Seto, Russell Shikami
  • Publication number: 20240023848
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned analyte sensor automatically or on demand upon request from a user.
    Type: Application
    Filed: February 17, 2023
    Publication date: January 25, 2024
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Publication number: 20240008779
    Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided, as well as methods of inserting medical devices.
    Type: Application
    Filed: September 25, 2023
    Publication date: January 11, 2024
    Inventors: Daniel H. Lee, Michael R. Love, Louis G. Pace, Phillip Yee
  • Patent number: 11852540
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer-storage media, for a device with improved ambient temperature detection. In some implementations, a device includes a housing that forms an interior space, and the housing includes an exterior surface, a pass-through region that defines a through-hole between the interior space to the exterior surface, and a recess at the exterior surface adjacent to the pass-through hole. The device includes a printed circuit board disposed within the interior space of the plastic housing.
    Type: Grant
    Filed: May 3, 2022
    Date of Patent: December 26, 2023
    Assignee: X Development LLC
    Inventor: Phillip Yee
  • Publication number: 20230268071
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: February 28, 2023
    Publication date: August 24, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Patent number: 11730429
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Grant
    Filed: January 20, 2022
    Date of Patent: August 22, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman, Erich Yen
  • Publication number: 20230238131
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: April 3, 2023
    Publication date: July 27, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20230218235
    Abstract: Disclosed are an apparatus and a stabilization assembly for supporting a device on a human head, including: a first frame having an annular shape with a first diameter; and a second frame having an annular shape with a second diameter, the second diameter being less than the first diameter. The second frame is concentric with the first frame and is mechanically coupled to the first frame by a pivot support that permits rotation of the second frame relative to the first frame. A tripod mount is mechanically coupled to the first frame, the tripod mount including legs configured to rest on the human head during use of the stabilization assembly. The stabilization assembly positions the device against the human head during use. The tripod mount includes three legs, each leg having a U-shape. For each leg, ends of the U-shaped leg connect to the first frame.
    Type: Application
    Filed: January 7, 2022
    Publication date: July 13, 2023
    Inventor: Phillip Yee
  • Patent number: 11583231
    Abstract: An electroencephalography (EEG) headset can include an arrangement of straps that provides the ability to adjust the size and shape of the headset once disposed on a user's head. In some implementations, the headset can include a first elastic strap extending from a first side of the headset to a second side of the headset along a topside of the headset. The headset can also include a second strap including at least one inelastic portion and at least one elastic portion, at least one EEG electrode coupled to the second strap, a third elastic strap extending from the first side of the headset to the second side of the headset along an underside of the headset, and a plurality of connectors that couple the elastic first strap, the second strap, or the third elastic strap.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: February 21, 2023
    Assignee: X Development LLC
    Inventor: Phillip Yee
  • Publication number: 20220401041
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: August 18, 2022
    Publication date: December 22, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20220359074
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 10, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20220333999
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer-storage media, for a device with improved ambient temperature detection. In some implementations, a device includes a housing that forms an interior space, and the housing includes an exterior surface, a pass-through region that defines a through-hole between the interior space to the exterior surface, and a recess at the exterior surface adjacent to the pass-through hole. The device includes a printed circuit board disposed within the interior space of the plastic housing.
    Type: Application
    Filed: May 3, 2022
    Publication date: October 20, 2022
    Inventor: Phillip Yee
  • Publication number: 20220240821
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: April 14, 2022
    Publication date: August 4, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20220233111
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: April 14, 2022
    Publication date: July 28, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20220233110
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: April 14, 2022
    Publication date: July 28, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Patent number: D956840
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: July 5, 2022
    Assignee: X Development LLC
    Inventors: Derek Werdenberg, Allen Richard Zhao, Phillip Yee, Joseph Hollis Sargent
  • Patent number: D957642
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: July 12, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Patent number: D957643
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: July 12, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee